Both The Scientist and Nature's The Great Beyond Blog are reporting that Mehar Manku will be the new editor-in-chief of Elsevier's controversial journal Medical Hypotheses. Manku, who has since 2004 served as a member of the journal's editorial board, "vows to maintain the journal's unusual aim of distributing novel, radical ideas in medicine and related biomedical sciences while employing a more traditional peer review process than the journal saw under its previous editor," according to The Scientist. In addition to his new role, Manku is the executive editor and editor-in-chief of Prostaglandins, Leukotrienes and Essential Fatty Acids, as well as a part-time chief scientist at biopharmaceutical firm Amarin Corporation, The Scientist reports. Manku says in a statement that the Medical Hypotheses team "will engage a medically qualified editorial board to get members more involved in the review system to help ensure radical new ideas and speculations in medicine are given open-minded consideration while ensuring scientific merit."
New Editor, New System
Jun 25, 2010